REFERENCES
- Hoodfar H, Assadpour S. The politics of population policy in the Islamic Republic of Iran. Stud Fam Plann 2000;31:19–34
- Aghajanian A, Mehryar AH. Fertility, contraceptive use and family planning program activity in Islamic Republic of Iran. Int Fam Plan Perspect 1999;25:68–77
- Darney PD. Hormonal implants: contraception for a new century. Am J Obstet Gynecol 1994;170:1536–43
- Hatcher RA, Rinehart W, Blackburn R, et al. The Essentials of Contraceptive Technology. Baltimore: Johns Hopkins School of Public Health, Population Information Program, 1997:4–19
- Farley TMM. Life-table methods for contraceptive research. Stat Med 1986;5:475–89
- Fisher AA, Prihartono J, Tuladhar J, et al. An assessmentof Norplant removal in Indonesia. Stud Fam Plann 1997;28:308–16
- Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility, 6th edn. Baltimore: Lippincott Williams & Wilkins, 1999:947–60
- Ping T, Shuhua Q, Huimin F, et al. Acceptance, efficacy, and side effects of Norplant implants in four counties in North China. Stud Fam Plann 1997;28:122–31
- Rehan N, Inayatullah A, Chaudhary I. Norplant: reasons for discontinuation and side-effects. Eur J Contracept Reprod Health Care 2000;5:113–18
- Chernichovsky D, Anson J. Cost recovery and the true cost-effectiveness of contraceptive provision. Int Fam Plann Perspect 1993;19:129–33
- Su-Juan G, Ming-Kun D, Ling-De Z, et al. A 5-year evaluation of Norplant contraceptive implants in China. Obstet Gynecol 1994;83:673–8
- Ortayli N, Amca B, Say L, et al. Acceptability of Norplant at a well-women clinic in Turkey. Eur J Contracept Reprod Health Care 2000;2:119–23
- Ebacher R, Prior S, Valdini A. Norplant utilization in a Latin inner-city population. J Health Care Poor Underserved 1999;10:85–9
- Hassan EO, Kafafi L, el Husseini M, et al. The acceptability of Norplant in Egypt. Adv Contracept 1992;8:331–48
- Rehan N, Inayatollah A, Chaudhary I. Norplant: users’ perspective in Pakistan. Adv Contracept 1999;15:95–107
- Barberis M, Harvey PD. Costs of family planning programmes in fourteen developing countries by method of service delivery. J Biosoc Sci 1997;29:219–33
- Alvarez-Sanchez F, Brache V, Thevenin F, et al. Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol 1996;174:911–26
- Trussell J, Leveque JA, Jacqueline D. The economic value of contraception: a comparison of 15 methods. Am J Public Health 1995;85:494–503
- Nakhaee N, Mirahmadizadeh A, A-Gorji H, et al. Assessing the cost-effectiveness of contraceptive methods in urban Iran (I.R.): a study in Shiraz. East Mediterr Health J 2003;in press
- Scott J. Norplant and women of color. In Samuels SE, Smith MD, eds. Dimensions of New Contraceptives: Norplant and Poor Women. Menlo Park, CA: Henry J. Kaiser Family Foundation, 1992:39–52
- Jain AK. Fertility reduction and the quality of family planning services. Stud Fam Plann 1989;20:1–16